Faron Pharmaceuticals - Innovatiivisia lääketieteen ratkaisuja (Osa 2)

Takaajille tuli reipas 24 miljoonaa osaketta ja niiden palkkio oli 2,9 miljoonaa euroa. Tästä laskettuna break even on jossain 0,38€ tasoilla.

In total, the Cornerstone Commitments and the primary and secondary subscriptions correspond to approximately 70 per cent of the total Offering. The remaining 24,471,573 shares will be allocated to investors who have previously agreed to subscribe for any Offer Shares not otherwise subscribed and paid for pursuant to the subscription rights or in the secondary subscription (“Subscription Guarantees”).

10 tykkäystä